Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate for Smoking Cessation
NCT00280839Phase 3Completed
- Sponsor
- Lindner Center of HOPE
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of topiramate in tobacco dependence, sponsored by Lindner Center of HOPE. Status: completed.
02
Drugs
topiramate
03
Conditions
tobacco dependence
Beyond the preview
Go deeper on NCT00280839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00280839.